Perspective Therapeutics FY2023 EPS $(0.14) Down From $(0.06) YoY, Sales $1.43M
Perspective Therapeutics FY2023 EPS $(0.14) Down From $(0.06) YoY, Sales $1.43M
Persective Therapeutics FY2023 每股收益为0.14美元，低于同比0.06美元，销售额为143万美元
Perspective Therapeutics (AMEX:CATX) reported quarterly losses of $(0.14) per share. This is a 133.33 percent decrease over losses of $(0.06) per share from the same period last year. The company reported $1.43 million in sales this quarter.
Perspective Therapeutics（美国证券交易所股票代码：CATX）公布的季度亏损为每股0.14美元。这比去年同期每股亏损0.06美元（0.06美元）下降了133.33％。该公司报告本季度销售额为143万美元。